These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7705097)

  • 1. Lea's Shield, a new barrier contraceptive preliminary clinical evaluations three-day tolerance study.
    Hunt WL; Gabbay L; Potts M
    Contraception; 1994 Dec; 50(6):551-61. PubMed ID: 7705097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
    Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
    Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
    Archer DF; Mauck CK; Viniegra-Sibal A; Anderson FD
    Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New device, "Lea's Shield," being evaluated in studies.
    Contracept Technol Update; 1991 Jul; 12(7):110-1. PubMed ID: 12284066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of use.
    Bounds W; Guillebaud J
    Br J Fam Plann; 1999 Jan; 24(4):117-20. PubMed ID: 10023094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lea's Shield: colposcopic and microbiological testing during 8 weeks of use.
    Mauck CK; Creinin MD; Rountree W; Callahan MM; Hillier SL
    Contraception; 2005 Jul; 72(1):53-9. PubMed ID: 15964293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of MRI to determine the in vivo position of a silicone vaginal barrier contraceptive device.
    Pretorius ES; Barnhart K; Timbers K; Mauck C
    Contraception; 2002 May; 65(5):343-6. PubMed ID: 12057786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future barrier methods.
    Contracept Rep; 1997 Mar; 8(1):9-13. PubMed ID: 12290347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a new intravaginal barrier contraceptive device (Femcap).
    Shihata AA; Gollub E
    Contraception; 1992 Dec; 46(6):511-9. PubMed ID: 1493711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a contraceptive device with MR imaging.
    Maldjian C; Pelosi MA; Pelosi MA; Adam R
    Magn Reson Imaging; 2001 Jun; 19(5):629-33. PubMed ID: 11672620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's in store for non-latex barrier methods.
    Contracept Technol Update; 1998 Mar; 19(3):40-1. PubMed ID: 12293273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
    Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ
    Contraception; 1992 May; 45(5):511-8. PubMed ID: 1623721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of a female condom on the female lower genital tract.
    Soper DE; Brockwell NJ; Dalton HP
    Contraception; 1991 Jul; 44(1):21-9. PubMed ID: 1893699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.
    Chvapil M; Droegemueller W; Heine MW; MacGregor JC; Dotters D
    Am J Obstet Gynecol; 1985 Feb; 151(3):325-9. PubMed ID: 2982268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive technologies: how much choice do we really have?
    Fishel J
    ZPG Report; 1997; 29(2):4-6. PubMed ID: 12293118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of Femcap used with and without spermicide. Postcoital testing.
    Mauck CK; Baker JM; Barr SP; Johanson W; Archer DF
    Contraception; 1997 Aug; 56(2):111-5. PubMed ID: 9315420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.
    Roumen FJ; Dieben TO
    Contraception; 1999 Jan; 59(1):59-62. PubMed ID: 10342086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
    Bounds W; Szarewski A; Lowe D; Guillebaud J
    Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cervico-vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring.
    Roumen FJ; Boon ME; van Velzen D; Dieben TO; Coelingh Bennink HJ
    Hum Reprod; 1996 Nov; 11(11):2443-8. PubMed ID: 8981130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
    Aznar R; Zamora G; Lozano M; Levi C
    Contraception; 1981 Sep; 24(3):235-44. PubMed ID: 7030612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.